Research October 08, 2021 Deciphering Mexican genome: challenge of oriGen project The oriGen project, an initiative TecSalud is participating in, hopes to crack the Mexican genome by studying 100,000 people to determine the genetic components associated with the population’s most common diseases.
Research October 01, 2021 TecSalud begins clinical trial of COVID antibody treatment TecSalud begins clinical trials of polyclonal antibodies to treat COVID-19 patients in collaboration with pharmaceutical company Inosan Biopharma.
Health September 23, 2021 Tec School of Medicine hosts international conference The School of Medicine and Health Sciences hosted the annual Universitas 21 Health Sciences Group conference.
Research September 03, 2021 Researchers patent plant-based therapy for an eye anomaly Researchers from the Tec’s School of Medicine have obtained a patent after researching a plant extract for an eye disease called pterygium.
Health July 13, 2021 Infectious disease specialist talks about COVID-19 vaccinations Reynaldo Lara, an infectious disease specialist at TecSalud, answers questions about whether it’s a good idea for people who’ve been vaccinated to take a different dose from another laboratory.
Health July 05, 2021 New COVID variants: what you should know New variants of the virus that causes COVID-19 make it spread easier and faster. A TecSalud expert answers questions about these variants.
Health June 25, 2021 The doctor who created an innovative health system in Mexico Dr. Guillermo Torre, researcher, clinician, and surgeon, has helped establish an innovative system at TecSalud, Tec de Monterrey’s health system.
Health May 12, 2021 Tec graduate researcher discovers new lung cell and wins US grant Lisandra Vila Ellis, who holds a medical degree from the Tec de Monterrey School of Medicine, has won a United States research project grant after discovering a new lung cell.
Research May 11, 2021 TecSalud will develop a protocol for cell therapy against COVID-19 TecSalud and NovocellBio signed a collaboration agreement to start the NK (natural killer) immune cell culture protocol.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
